Correspondence 0001575872-23-000966 from 60 DEGREES PHARMACEUTICALS, INC. (SXTP)
60 DEGREES PHARMACEUTICALS, INC.
Date: June 14, 2023 · CIK: 0001946563 · Accession: 0001575872-23-000966
AI Filing Summary & Sentiment
File numbers found in text: 333-269483
Show Raw Text
CORRESP
1
filename1.htm
60 Degrees Pharmaceuticals, Inc.
1025 Connecticut Avenue NW Suite 1000
Washington, D.C. 20036
June 14, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Tim Buchmiller, Senior Attorney
Joshua Gorsky, Attorney Adviser
Re: 60 Degrees Pharmaceuticals,
Inc.
Registration
Statement on Form S-1, as amended
Initially Filed
January 31, 2023
File No. 333-269483
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence
via EDGAR on June 12, 2023, in which we requested the acceleration of the effective date of the above-referenced Registration Statement
for Wednesday, June 14, 2023, at 5:00pm Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. We are
no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for
acceleration of the effective date.
Very truly yours,
By:
/s/ Geoffrey S. Dow
Name: Geoffrey S. Dow
Title: Chief Executive Officer
cc:
Ross D. Carmel, Esq., Carmel, Milazzo & Feil LLP